Thalidomide in Treating Patients With Gynecologic Sarcomas
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Thalidomide may stop the growth of gynecologic sarcomas by stopping blood flow to
the tumor.
PURPOSE: Phase II trial to study the effectiveness of thalidomide in treating patients who
have recurrent or persistent gynecologic sarcomas.